Skip to main content
Top
Published in: Malaria Journal 1/2023

Open Access 01-12-2023 | Plasmodium Vivax | Research

Imported and indigenous Plasmodium Vivax and Plasmodium Falciparum malaria in the Hubei Province of China, 2005–2019

Authors: Dongni Wu, Hong Zhu, Lun Wan, Juan Zhang, Wen Lin, Lingcong Sun, Huaxun Zhang, Si Liu, Eimear Cleary, Andrew J. Tatem, Jing Xia, Shengjie Lai

Published in: Malaria Journal | Issue 1/2023

Login to get access

Abstract

Background

The Hubei Province in China reported its last indigenous malaria case in September 2012, but imported malaria cases, particularly those related to Plasmodium vivax and Plasmodium falciparum, threaten Hubei’s malaria-free status. This study investigated the epidemiological changes in P. vivax and P. falciparum malaria in this province to provide scientific evidence for preventing malaria resurgence.

Methods

The prevalence, demographic characteristics, seasonal features, and geographical distribution of malaria were assessed using surveillance data and were compared across three stages: control stage (2005–2009) and elimination stages I (2010–2014) and II (2015–2019).

Results

In 2005–2019, 8483 malaria cases were reported, including 5599 indigenous P. vivax cases, 275 imported P. vivax cases, 866 imported P. falciparum cases, and 1743 other cases. Imported P. falciparum cases accounted for 0.07% of all cases reported in 2005, but increased to 78.81% in 2019. Most imported P. vivax and P. falciparum malaria occurred among males, aged 21–60 years, during elimination stages I and II. The number of regions affected by imported P. falciparum and P. vivax increased markedly in Hubei from the control stage to elimination stage II. Overall, 1125 imported P. vivax and P. falciparum cases were detected from 47 other nations. Eight imported cases were detected from other provinces in China. From the control stage to elimination stage II, the number of cases of malaria imported from African countries increased, and that of cases imported from Southeast Asian countries decreased.

Conclusions

Although Hubei has achieved malaria elimination, it faces challenges in maintaining this status. Hence, imported malaria surveillance need to be strengthened to reduce the risk of malaria re-introduction.
Literature
1.
go back to reference WHO. World malaria report 2022. Geneva,: World Health Organization; 2022. WHO. World malaria report 2022. Geneva,: World Health Organization; 2022.
2.
go back to reference Zhou ZJ. The malaria situation in the people’s Republic of China. Bull World Health Organ. 1981;59:931–6.PubMed Zhou ZJ. The malaria situation in the people’s Republic of China. Bull World Health Organ. 1981;59:931–6.PubMed
3.
go back to reference Zhou XN, Zhou SS, Xia ZG. Malaria elimination strategy and challenges in People’s Republic of China. Malar J. 2012;11(Suppl 1):1. Zhou XN, Zhou SS, Xia ZG. Malaria elimination strategy and challenges in People’s Republic of China. Malar J. 2012;11(Suppl 1):1.
4.
go back to reference Sun JL, Zhou S, Geng QB, Zhang Q, Zhang ZK, Zheng CJ, et al. Comparative evaluation of the diagnosis, reporting and investigation of Malaria cases in China, 2005–2014: transition from control to elimination for the national Malaria programme. Infect Dis Poverty. 2016;5:65.CrossRefPubMedCentralPubMed Sun JL, Zhou S, Geng QB, Zhang Q, Zhang ZK, Zheng CJ, et al. Comparative evaluation of the diagnosis, reporting and investigation of Malaria cases in China, 2005–2014: transition from control to elimination for the national Malaria programme. Infect Dis Poverty. 2016;5:65.CrossRefPubMedCentralPubMed
5.
go back to reference Ministry of Health of China. National Malaria elimination action plan (2010–2020) (in Chinese). Beijing: Ministry of Health; 2010. Ministry of Health of China. National Malaria elimination action plan (2010–2020) (in Chinese). Beijing: Ministry of Health; 2010.
6.
go back to reference Cao J, Sturrock HJ, Cotter C, Zhou S, Zhou HY, Liu YB, et al. Communicating and monitoring surveillance and response activities for Malaria elimination: China’s 1-3-7 strategy. PLoS Med. 2014;11:e1001642.CrossRefPubMedCentralPubMed Cao J, Sturrock HJ, Cotter C, Zhou S, Zhou HY, Liu YB, et al. Communicating and monitoring surveillance and response activities for Malaria elimination: China’s 1-3-7 strategy. PLoS Med. 2014;11:e1001642.CrossRefPubMedCentralPubMed
7.
go back to reference Lai SJ, Sun JL, Ruktanonchai NW, Zhou S, Yu JX, Routledge I, et al. Changing epidemiology and challenges of Malaria in China towards elimination. Malar J. 2019;18:107.CrossRefPubMedCentralPubMed Lai SJ, Sun JL, Ruktanonchai NW, Zhou S, Yu JX, Routledge I, et al. Changing epidemiology and challenges of Malaria in China towards elimination. Malar J. 2019;18:107.CrossRefPubMedCentralPubMed
8.
go back to reference Huang GQ, Yan BW, Yuan FY, Pei SJ. Thirty-year experience of malaria control in Hubei Province (in Chinese). J Public Health Prev Med. 2004;15:66–8. Huang GQ, Yan BW, Yuan FY, Pei SJ. Thirty-year experience of malaria control in Hubei Province (in Chinese). J Public Health Prev Med. 2004;15:66–8.
9.
go back to reference Xia J, Cai SX, Lin W, Pei SJ, Li KJ, Sun LC, et al. Epidemiological analysis of malaria prevalence in Hubei Province from 2010 to 2014 (in Chinese). Chin J Schisto Control. 2016;28:247. Xia J, Cai SX, Lin W, Pei SJ, Li KJ, Sun LC, et al. Epidemiological analysis of malaria prevalence in Hubei Province from 2010 to 2014 (in Chinese). Chin J Schisto Control. 2016;28:247.
10.
go back to reference Xia J, Huang XB, Sun LC, Zhu H, Lin W, Dong XR, et al. Epidemiological characteristics of Malaria from control to elimination in Hubei Province, China, 2005–2016. Malar J. 2018;17:81.CrossRefPubMedCentralPubMed Xia J, Huang XB, Sun LC, Zhu H, Lin W, Dong XR, et al. Epidemiological characteristics of Malaria from control to elimination in Hubei Province, China, 2005–2016. Malar J. 2018;17:81.CrossRefPubMedCentralPubMed
11.
go back to reference Lai SJ, Wardrop NA, Huang ZJ, Bosco C, Sun JL, Bird T, et al. Plasmodium Falciparum Malaria importation from Africa to China and its mortality: an analysis of driving factors. Sci Rep. 2016;6:39524.CrossRefPubMedCentralPubMed Lai SJ, Wardrop NA, Huang ZJ, Bosco C, Sun JL, Bird T, et al. Plasmodium Falciparum Malaria importation from Africa to China and its mortality: an analysis of driving factors. Sci Rep. 2016;6:39524.CrossRefPubMedCentralPubMed
12.
go back to reference WHO. Guidelines on prevention of the reintroduction of Malaria. Geneva: World Health Organization; 2007. WHO. Guidelines on prevention of the reintroduction of Malaria. Geneva: World Health Organization; 2007.
13.
go back to reference Mironova VA, Shartova NV, Beljaev AE, Varentsov MI, Korennoy FI, Grishchenko MY. Re-introduction of vivax Malaria in a temperate area (Moscow region, Russia): a geographic investigation. Malar J. 2020;19:116.CrossRefPubMedCentralPubMed Mironova VA, Shartova NV, Beljaev AE, Varentsov MI, Korennoy FI, Grishchenko MY. Re-introduction of vivax Malaria in a temperate area (Moscow region, Russia): a geographic investigation. Malar J. 2020;19:116.CrossRefPubMedCentralPubMed
14.
go back to reference Sun YW, Yu DM, Chen J, Li X, Wang B, Wang ZJ, et al. Two individual incidences of vivax malaria in Dandong municipality of Liaoning Province (in Chinese). Chin J Public Health. 2017;33:314–12. Sun YW, Yu DM, Chen J, Li X, Wang B, Wang ZJ, et al. Two individual incidences of vivax malaria in Dandong municipality of Liaoning Province (in Chinese). Chin J Public Health. 2017;33:314–12.
15.
go back to reference Xia J, Wu DN, Wu K, Zhu H, Sun LC, Lin W, et al. Epidemiology of Plasmodium Falciparum Malaria and risk factors for severe Disease in Hubei Province, China. Am J Trop Med Hyg. 2020;103:1534–9.CrossRefPubMedCentralPubMed Xia J, Wu DN, Wu K, Zhu H, Sun LC, Lin W, et al. Epidemiology of Plasmodium Falciparum Malaria and risk factors for severe Disease in Hubei Province, China. Am J Trop Med Hyg. 2020;103:1534–9.CrossRefPubMedCentralPubMed
16.
go back to reference Hu LQ, Pei SJ, Huang GQ, Zhang HX, Zuo SL, Pen H, et al. Analysis of malaria epidemic in Hubei, 2006 (in Chinese). J Public Health Prev Med. 2008;19:42–5. Hu LQ, Pei SJ, Huang GQ, Zhang HX, Zuo SL, Pen H, et al. Analysis of malaria epidemic in Hubei, 2006 (in Chinese). J Public Health Prev Med. 2008;19:42–5.
17.
go back to reference Li KJ, Shang XP, Pi Q, Zhang HX, Tong L. Analysis on the density and ecological habit of the main malaria vector Anopheles in Hubei Province (in Chinese). Int J Med Parasit Dis. 2015;42:328–31. Li KJ, Shang XP, Pi Q, Zhang HX, Tong L. Analysis on the density and ecological habit of the main malaria vector Anopheles in Hubei Province (in Chinese). Int J Med Parasit Dis. 2015;42:328–31.
18.
go back to reference Wan L, Zhang HX, Xia J, Wu DN, Zhang J, Cao MM, et al. An investigation of malaria vector populations in historical distribution areas of Anopheles Lesteri in Hubei province (in Chinese). J Trop Med. 2022;22:1270–4. Wan L, Zhang HX, Xia J, Wu DN, Zhang J, Cao MM, et al. An investigation of malaria vector populations in historical distribution areas of Anopheles Lesteri in Hubei province (in Chinese). J Trop Med. 2022;22:1270–4.
19.
go back to reference National Health and Family Planning Commission of China. Diagnostic criteria for malaria (WS259–2006) (in Chinese). National Health and Family Planning Commission of China. Diagnostic criteria for malaria (WS259–2006) (in Chinese).
20.
go back to reference Chinese Center for Disease Control and Prevention. Technical Guidline for Malaria Elimination (2011 Edition) (in Chinese). Chinese Center for Disease Control and Prevention. Technical Guidline for Malaria Elimination (2011 Edition) (in Chinese).
21.
go back to reference Wan L, Zhang HX, Li KJ, Zhang C, Cao MM, Wu DN, et al. Surveillance of malaria-transmitting vectors in Hubei Province from 2018 to 2020 (in Chinese). Chin J Parasitol Parasit Dis. 2021;39:592–8. Wan L, Zhang HX, Li KJ, Zhang C, Cao MM, Wu DN, et al. Surveillance of malaria-transmitting vectors in Hubei Province from 2018 to 2020 (in Chinese). Chin J Parasitol Parasit Dis. 2021;39:592–8.
22.
go back to reference National Health and Family Planning Commission of People’s Republic of China. WS/T 485-2016:Technical regulations for applications of antimalarial (in Chinese). National Health and Family Planning Commission of People’s Republic of China. WS/T 485-2016:Technical regulations for applications of antimalarial (in Chinese).
23.
go back to reference Zhang Q, Lai SJ, Zheng CJ, Zhang HL, Zhou S, Hu WB, et al. The epidemiology of Plasmodium Vivax and Plasmodium Falciparum Malaria in China, 2004–2012: from intensified control to elimination. Malar J. 2014;13:419.CrossRefPubMedCentralPubMed Zhang Q, Lai SJ, Zheng CJ, Zhang HL, Zhou S, Hu WB, et al. The epidemiology of Plasmodium Vivax and Plasmodium Falciparum Malaria in China, 2004–2012: from intensified control to elimination. Malar J. 2014;13:419.CrossRefPubMedCentralPubMed
24.
go back to reference Yu T, Fu YG, Kong XL, Liu X, Yan G, Wang YB, et al. Epidemiological characteristics of imported Malaria in Shandong province, China, from 2012–2017. Sci Rep. 2020;10:7568.CrossRefPubMedCentralPubMed Yu T, Fu YG, Kong XL, Liu X, Yan G, Wang YB, et al. Epidemiological characteristics of imported Malaria in Shandong province, China, from 2012–2017. Sci Rep. 2020;10:7568.CrossRefPubMedCentralPubMed
25.
go back to reference Xie YH, Ma CS, Zeng W, Wang GZ, Meng F, Li YC, et al. The epidemiology of imported malaria in Hainan, 2011–2016 (in Chinese). China Trop Med. 2018;3:252–5. Xie YH, Ma CS, Zeng W, Wang GZ, Meng F, Li YC, et al. The epidemiology of imported malaria in Hainan, 2011–2016 (in Chinese). China Trop Med. 2018;3:252–5.
26.
go back to reference Huang GQ, Li KJ, Zhang HX, Yang Y, Wu K, Cao YJ, et al. Investigation and analysis of malaria prevention and control measures for migrant workers to high prevalence area in Hubei province (in Chinese). J Public Health Prev Med. 2014;25:30–3. Huang GQ, Li KJ, Zhang HX, Yang Y, Wu K, Cao YJ, et al. Investigation and analysis of malaria prevention and control measures for migrant workers to high prevalence area in Hubei province (in Chinese). J Public Health Prev Med. 2014;25:30–3.
27.
go back to reference Xia J, Cai SX, Zhang HX, Lin W, Fan YZ, Qiu J, et al. Spatial, temporal, and spatiotemporal analysis of Malaria in Hubei Province, China from 2004–2011. Malar J. 2015;14:145.CrossRefPubMedCentralPubMed Xia J, Cai SX, Zhang HX, Lin W, Fan YZ, Qiu J, et al. Spatial, temporal, and spatiotemporal analysis of Malaria in Hubei Province, China from 2004–2011. Malar J. 2015;14:145.CrossRefPubMedCentralPubMed
28.
go back to reference Li KJ, Cai SX, Lin W, Xia J, Pei SJ, Zhang HX. Analysis of malaria epidemic situation and control in Hubei Province from 1974 to 2015 (in Chinese). Chin J Schisto Control. 2016;28:393–6. Li KJ, Cai SX, Lin W, Xia J, Pei SJ, Zhang HX. Analysis of malaria epidemic situation and control in Hubei Province from 1974 to 2015 (in Chinese). Chin J Schisto Control. 2016;28:393–6.
29.
go back to reference Wu DN, Xia J, Li KJ, Zhang HX, Sun LC, Dong XR, et al. Study on the application of Wondfo Rapid Diagnostic Kit for detecting of imported malaria (in Chinese). J Public Health Prev Med. 2020;31:46–9. Wu DN, Xia J, Li KJ, Zhang HX, Sun LC, Dong XR, et al. Study on the application of Wondfo Rapid Diagnostic Kit for detecting of imported malaria (in Chinese). J Public Health Prev Med. 2020;31:46–9.
30.
go back to reference Zhang Q, Geng QB, Sun JL, Zhang ZK, Lai SJ, Zhou S, et al. Epidemiological analysis of the deaths of malaria in China, 2005–2014 (in Chinese). Chin J Prev Med. 2016;50:302–5. Zhang Q, Geng QB, Sun JL, Zhang ZK, Lai SJ, Zhou S, et al. Epidemiological analysis of the deaths of malaria in China, 2005–2014 (in Chinese). Chin J Prev Med. 2016;50:302–5.
31.
go back to reference Li KJ, Huang GQ, Zhang HX, Lin W, Dong XR, Pi Q, et al. Epidemic situation and control strategy of imported malaria in Hubei Province from 2006 to 2011 (in Chinese). Chin J Schisto Control. 2013;25:259–62. Li KJ, Huang GQ, Zhang HX, Lin W, Dong XR, Pi Q, et al. Epidemic situation and control strategy of imported malaria in Hubei Province from 2006 to 2011 (in Chinese). Chin J Schisto Control. 2013;25:259–62.
32.
go back to reference Wu DN, Xia J, Sun LC, Zhang HX, Wan L, Zhang J, et al. Epidemic characteristics of imported malaria in Hubei, 2015–2019 (in Chinese). China Trop Med. 2021;1:19–23. Wu DN, Xia J, Sun LC, Zhang HX, Wan L, Zhang J, et al. Epidemic characteristics of imported malaria in Hubei, 2015–2019 (in Chinese). China Trop Med. 2021;1:19–23.
33.
go back to reference Xia J, Wu DN, Zhu H, Wan L, Zhang J, Lin W, et al. Progress of malaria control and elimination of Hubei Province, China (in Chinese). Chin J Parasitol Parasit Dis. 2021;39:565–71. Xia J, Wu DN, Zhu H, Wan L, Zhang J, Lin W, et al. Progress of malaria control and elimination of Hubei Province, China (in Chinese). Chin J Parasitol Parasit Dis. 2021;39:565–71.
34.
go back to reference Wang DQ, Prosper C, Yeromin M, Tegemeo G, Mihayo GM, Rashid K, et al. Application of community-based and integrated strategy to reduce malaria disease burden in southern Tanzania: the study protocol of China–UK–Tanzania pilot project on malaria control. Malar J. 2019;8:4. Wang DQ, Prosper C, Yeromin M, Tegemeo G, Mihayo GM, Rashid K, et al. Application of community-based and integrated strategy to reduce malaria disease burden in southern Tanzania: the study protocol of China–UK–Tanzania pilot project on malaria control. Malar J. 2019;8:4.
35.
go back to reference Wang DQ, Lv S, Ding W, Lu SN, Zhang HW, Kassegne K, et al. Could China’s journey of Malaria elimination extend to Africa? Infect Dis Poverty. 2022;11:55.CrossRefPubMedCentralPubMed Wang DQ, Lv S, Ding W, Lu SN, Zhang HW, Kassegne K, et al. Could China’s journey of Malaria elimination extend to Africa? Infect Dis Poverty. 2022;11:55.CrossRefPubMedCentralPubMed
36.
go back to reference Sudathip P, Naowarat S, Kitchakarn S, Gopinath D, Bisanzio D, Pinyajeerapat N, et al. Assessing Thailand’s 1-3-7 surveillance strategy in accelerating malaria elimination. Malar J.2022;21:222. Sudathip P, Naowarat S, Kitchakarn S, Gopinath D, Bisanzio D, Pinyajeerapat N, et al. Assessing Thailand’s 1-3-7 surveillance strategy in accelerating malaria elimination. Malar J.2022;21:222.
37.
go back to reference Yin JH, Zhang L, Yi BY, Zhou SS, Xia ZG. Imported malaria from land bordering countries in China: a challenge in preventing the reestablishment of malaria transmission. Travel Med Infect Dis. 2023;53:102575.CrossRefPubMedCentralPubMed Yin JH, Zhang L, Yi BY, Zhou SS, Xia ZG. Imported malaria from land bordering countries in China: a challenge in preventing the reestablishment of malaria transmission. Travel Med Infect Dis. 2023;53:102575.CrossRefPubMedCentralPubMed
Metadata
Title
Imported and indigenous Plasmodium Vivax and Plasmodium Falciparum malaria in the Hubei Province of China, 2005–2019
Authors
Dongni Wu
Hong Zhu
Lun Wan
Juan Zhang
Wen Lin
Lingcong Sun
Huaxun Zhang
Si Liu
Eimear Cleary
Andrew J. Tatem
Jing Xia
Shengjie Lai
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2023
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-023-04752-7

Other articles of this Issue 1/2023

Malaria Journal 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.